Insider Selling: Phreesia (NYSE:PHR) Insider Sells 1,743 Shares of Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 1,743 shares of the stock in a transaction on Thursday, January 15th. The shares were sold at an average price of $16.38, for a total value of $28,550.34. Following the completion of the transaction, the insider directly owned 229,980 shares in the company, valued at $3,767,072.40. This trade represents a 0.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

David Linetsky also recently made the following trade(s):

• On Friday, January 16th, David Linetsky sold 6,038 shares of Phreesia stock. The stock was sold at an average price of $16.36, for a total value of $98,781.68.
• On Thursday, January 8th, David Linetsky sold 6,106 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total value of $103,863.06.
• On Wednesday, December 17th, David Linetsky sold 94 shares of Phreesia stock. The stock was sold at an average price of $16.49, for a total value of $1,550.06.

Phreesia Stock Down 3.8%

PHR traded down $0.63 on Tuesday, reaching $15.76. The company’s stock had a trading volume of 888,246 shares, compared to its average volume of 1,011,187. The company has a market capitalization of $950.23 million, a price-to-earnings ratio of -157.59 and a beta of 0.61. Phreesia, Inc. has a fifty-two week low of $15.41 and a fifty-two week high of $32.76. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average of $18.24 and a two-hundred day moving average of $23.18.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.25) EPS. As a group, analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Wells Fargo & Company started coverage on Phreesia in a research report on Thursday, January 8th. They set an “overweight” rating and a $30.00 target price on the stock. Barclays cut their price target on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 16th. JPMorgan Chase & Co. decreased their price objective on Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a report on Tuesday, December 9th. Zacks Research lowered shares of Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Finally, Royal Bank Of Canada assumed coverage on shares of Phreesia in a report on Friday, January 9th. They issued a “moderate buy” rating and a $26.00 target price on the stock. Seventeen investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $30.06.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Federated Hermes Inc. acquired a new position in shares of Phreesia in the third quarter valued at approximately $32,000. Asset Management One Co. Ltd. acquired a new stake in shares of Phreesia during the third quarter worth $45,000. State of Alaska Department of Revenue acquired a new stake in shares of Phreesia during the third quarter worth $83,000. Farther Finance Advisors LLC grew its position in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after buying an additional 3,000 shares during the last quarter. Finally, Anchor Investment Management LLC acquired a new position in Phreesia in the 3rd quarter valued at $118,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.